Opportunity Information: Apply for PA 15 199
Apply for PA 15 199
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Studies at Periviable Gestation (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on May 4, 2015 and posted on May 4, 2015.
- Applicants must submit their applications by Sep 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments State governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Native American tribal governments (Federally recognized) Independent school districts Public and State controlled institutions of higher education Private institutions of higher education County governments Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Studies at Periviable Gestation (R03) funding opportunity (PA 15-199) is an NIH small grant program aimed at building practical evidence to improve clinical decision-making and care for pregnancies and newborns at the edge of viability. The central goal is to support focused research that can guide therapies and treatment strategies during periviable gestational ages, where clinical choices are often urgent, outcomes are uncertain, and practices can vary widely across hospitals and providers. Projects supported under this FOA are intended to strengthen the real-world evidence base that informs how clinicians manage the mother-infant pair during threatened extremely preterm birth, delivery, and the immediate newborn period, with an emphasis on generating data that can meaningfully shape care approaches.
This opportunity is offered by the National Institutes of Health under the grant funding instrument type, using the R03 mechanism, which is typically designed for smaller, well-defined projects such as pilot studies, feasibility work, secondary analyses, development of research methods, or other early-stage investigations that can produce actionable findings or set the stage for larger future studies. The award ceiling listed for this announcement is $50,000, and there is no cost-sharing or matching requirement, which means applicants are not required to contribute additional non-federal funds as a condition of receiving an award.
The FOA falls under the broader activity area of health, income security, and social services, and it is associated with CFDA number 93.865, which corresponds to the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) extramural research portfolio. While the summary statement of the FOA is brief, the topic area clearly targets a high-stakes clinical window: periviable gestation, where treatment decisions may involve maternal interventions (such as strategies to optimize pregnancy continuation or improve neonatal outcomes) as well as neonatal interventions (such as delivery room management, respiratory support, neuroprotection approaches, infection prevention, and other early-life care decisions). The intent is not simply to describe outcomes, but to generate evidence that helps guide what to do, when to do it, and for whom, recognizing that both maternal and infant considerations are tightly linked at these gestational ages.
Eligibility under PA 15-199 is broad and includes many organization types that commonly participate in biomedical and health services research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits with or without 501(c)(3) status (other than institutions of higher education), for-profit organizations other than small businesses, small businesses, and multiple levels of government entities such as state, county, city or township governments, special district governments, and independent school districts. The FOA also allows participation from public housing authorities/Indian housing authorities. Importantly, the eligibility list explicitly expands to include a range of mission-driven and equity-focused institutions and organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations are also included, as are eligible federal agencies, U.S. territories or possessions, regional organizations, and tribal governments (both federally recognized and other than federally recognized). Non-U.S. entities (foreign organizations) are listed as eligible as well, which signals that NIH was open to globally relevant evidence generation, provided other NIH policy requirements were met.
Administratively, this opportunity was posted and created on May 4, 2015. The original and current closing date were both September 7, 2018, and the opportunity was archived on October 8, 2018, meaning it is no longer accepting applications under that specific announcement. For full details, NIH directed applicants to the official FOA text at http://grants.nih.gov/grants/guide/pa-files/PA-15-199.html, which would have contained the specific scientific scope, application requirements, review criteria, budget rules typical to the R03 mechanism, and any special instructions relevant to periviable gestation research.
For questions related to accessing the announcement electronically or technical linking issues, the contact provided is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the "Studies at Periviable Gestation (R03)" funding opportunity?
It is an NIH small grant funding opportunity (PA 15-199) that supported focused research to build practical evidence for improving clinical decision-making and care for pregnancies and newborns at the edge of viability (periviable gestational ages). The emphasis was on generating data that can meaningfully shape real-world care approaches when outcomes are uncertain and practice varies across hospitals and providers.
What is the main goal of this opportunity?
The central goal was to strengthen the evidence base that informs how clinicians manage the mother-infant pair during threatened extremely preterm birth, delivery, and the immediate newborn period, particularly in urgent, high-stakes situations where clinical choices must be made quickly and standards of care can differ.
What does "periviable gestation" mean in the context of this FOA?
Within the information provided, periviable gestation refers to a high-risk clinical window at the edge of viability where treatment decisions are time-sensitive, outcomes are uncertain, and care practices may vary widely. The FOA targeted research intended to guide what to do, when to do it, and for whom during this period.
What types of research projects were intended to be supported?
The announcement described support for smaller, well-defined projects aligned with the NIH R03 mechanism. Examples listed include pilot studies, feasibility work, secondary analyses, development of research methods, or other early-stage investigations that could produce actionable findings or help lay the groundwork for larger future studies.
What clinical areas or interventions were within scope?
The scope highlighted both maternal and neonatal interventions during periviable gestational ages. Examples mentioned include maternal strategies to optimize pregnancy continuation or improve neonatal outcomes, and neonatal approaches such as delivery room management, respiratory support, neuroprotection approaches, infection prevention, and other immediate early-life care decisions.
Was the focus only on describing outcomes, or on informing treatment decisions?
The intent was not simply to describe outcomes. The stated emphasis was on producing evidence that helps guide clinical decision-making, including what interventions to use, when to use them, and which patients are most likely to benefit, recognizing the linked nature of maternal and infant considerations at these gestational ages.
Which federal agency offered this opportunity?
This opportunity was offered by the National Institutes of Health (NIH).
What grant mechanism and instrument type were used?
The FOA used the NIH R03 mechanism, described as a small grant program typically used for smaller, well-defined research projects.
What was the maximum award amount (award ceiling)?
The award ceiling listed for this announcement was $50,000.
Was cost sharing or matching required?
No. The information provided states there was no cost-sharing or matching requirement, meaning applicants were not required to contribute additional non-federal funds as a condition of receiving an award.
What CFDA number is associated with this opportunity?
The FOA is associated with CFDA number 93.865, corresponding to the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) extramural research portfolio.
What broad activity area was this FOA categorized under?
It was listed under the broader activity area of health, income security, and social services.
Who was eligible to apply?
Eligibility was described as broad and included many organization types, such as public and state-controlled institutions of higher education; private institutions of higher education; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and multiple government entities (state, county, city/township, special district, and independent school districts). Public housing authorities/Indian housing authorities were also included.
Were minority-serving institutions and equity-focused organizations eligible?
Yes. The eligibility list explicitly included Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations were also included.
Could government and tribal entities apply?
Yes. Eligible entities included state and local governments, eligible federal agencies, U.S. territories or possessions, regional organizations, and tribal governments (both federally recognized and other than federally recognized).
Were non-U.S. (foreign) organizations eligible?
Yes. Non-U.S. entities (foreign organizations) were listed as eligible in the information provided.
Is this funding opportunity still open for applications?
No. The opportunity is archived and is no longer accepting applications under that specific announcement.
What were the key dates for this FOA?
It was posted and created on May 4, 2015. The original closing date and the current closing date were both September 7, 2018. It was archived on October 8, 2018.
Where could applicants find the official FOA text and full requirements?
NIH directed applicants to the official FOA text at http://grants.nih.gov/grants/guide/pa-files/PA-15-199.html, which would have contained the detailed scientific scope, application requirements, review criteria, and budget rules typical to the R03 mechanism.
Who was the contact for technical or electronic access issues with the announcement?
For questions related to accessing the announcement electronically or technical linking issues, the contact provided was the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Does the provided information include specific submission instructions or review criteria?
No. The information provided notes that those details would have been in the official FOA text linked by NIH.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Studies at Periviable Gestation (R01)
Previous opportunity: FY 2015 Bank Enterprise Award Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 199
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 199) also looked into and applied for these:
| Funding Opportunity |
|---|
| Studies at Periviable Gestation (R01) Apply for PA 15 200 Funding Number: PA 15 200 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Studies at Periviable Gestation (R21) Apply for PA 15 198 Funding Number: PA 15 198 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| National Centers for Translational Research in Reproduction and Infertility (P50) Apply for RFA HD 16 010 Funding Number: RFA HD 16 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,200,000 |
| Non or Minimally Invasive Methods to Measure Biochemical Substances for Neonatal and Perinatal Clinical Care and Research (R41) Apply for RFA HD 16 028 Funding Number: RFA HD 16 028 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Bioengineering Research Partnership (BRP) Non or Minimally Invasive Methods to Measure Biochemical Substances during Neonatal and Perinatal Patient Care and Research (R01) Apply for PAR 15 285 Funding Number: PAR 15 285 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| HIV infected Adolescents Transitioning from Pediatric to the Adult Care Settings (R01) Apply for RFA HD 16 033 Funding Number: RFA HD 16 033 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $225,000 |
| HIV infected Adolescents Transitioning from Pediatric to the Adult Care Settings (R21) Apply for RFA HD 16 034 Funding Number: RFA HD 16 034 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Secondary Analysis of Existing Databases in Traumatic Brain Injury to Explore Outcomes Relevant to Medical Rehabilitation (R21) Apply for RFA HD 16 001 Funding Number: RFA HD 16 001 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Neurodevelopmental Assessment of Infants and Children in Resource Limited Settings (R43/R44) Apply for RFA HD 16 024 Funding Number: RFA HD 16 024 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Neurodevelopmental Assessment of Infants and Children in Resource Limited Settings (R41/R42) Apply for RFA HD 16 025 Funding Number: RFA HD 16 025 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 16 009 Funding Number: RFA HD 16 009 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Pelvic Floor Disorders Network Clinical Sites (UG1) Apply for RFA HD 16 012 Funding Number: RFA HD 16 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $180,000 |
| Pelvic Floor Disorders Network Data Coordinating Center (U24) Apply for RFA HD 16 011 Funding Number: RFA HD 16 011 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE) in Maternal and Child Health (R15) Apply for PAR 15 319 Funding Number: PAR 15 319 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Tools for Assessment and Improvement of Neurologic Outcomes (R41/R42) Apply for RFA HD 16 006 Funding Number: RFA HD 16 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Tools for Assessment and Improvement of Neurologic Outcomes (R43/R44) Apply for RFA HD 16 007 Funding Number: RFA HD 16 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| CAPSTONE Centers for Multidisciplinary Research and Training in Child Abuse and Neglect (P50) Apply for RFA HD 16 002 Funding Number: RFA HD 16 002 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Mechanisms of Adverse Drug Effects in Children (R01) Apply for PAR 08 248 Funding Number: PAR 08 248 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Mechanisms of Adverse Drug Reactions in Children (R03) Apply for PAR 08 249 Funding Number: PAR 08 249 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Contextual Approaches to Prevention of Unintended Pregnancy (R01) Apply for PA 09 014 Funding Number: PA 09 014 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 199", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.